Evidence map›Paper›PMID 33257424›Full record

Observational studyClinical cancer research : an official journal of the American Association for Cancer Research2021

Early Adaptation of Colorectal Cancer Cells to the Peritoneal Cavity Is Associated with Activation of "Stemness" Programs and Local Inflammation.

Jorge Barriuso, Raghavendar T Nagaraju, Shreya Belgamwar, Bipasha Chakrabarty, George J Burghel, Helene Schlecht, Lucy Foster, Elaine Kilgour, Andrew J Wallace, Michael Braun and 6 more

Open access · greenAbstract readObservational Study
In one paragraph

Observational study in Clinical cancer research : an official journal of the American Association for Cancer Research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 17 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 5 institutions in 2 countries.

Jorge BarriusoColorectal and Peritoneal Oncology Centre, The Christie NHS Foundation Trust, Manchester, England, United Kingdom. jorge.barriuso@manchester.ac.uk omer.aziz@manchester.ac.uk.ORCID 0000-0002-5641-9105
Raghavendar T NagarajuColorectal and Peritoneal Oncology Centre, The Christie NHS Foundation Trust, Manchester, England, United Kingdom.ORCID 0000-0002-6891-5181
Shreya BelgamwarColorectal and Peritoneal Oncology Centre, The Christie NHS Foundation Trust, Manchester, England, United Kingdom.
Bipasha ChakrabartyColorectal and Peritoneal Oncology Centre, The Christie NHS Foundation Trust, Manchester, England, United Kingdom.
George J BurghelNW GLH (Manchester), Manchester Centre for Genomic Medicine, Manchester University NHS Foundation Trust, Manchester, England, United Kingdom.
Helene SchlechtNW GLH (Manchester), Manchester Centre for Genomic Medicine, Manchester University NHS Foundation Trust, Manchester, England, United Kingdom.
Lucy FosterDepartment of Pathology, Manchester University NHS Foundation Trust, Manchester, England, United Kingdom.
Elaine KilgourCancer Research UK Manchester Institute, Cancer Biomarker Centre, University of Manchester, Manchester, England, United Kingdom.
Andrew J WallaceNW GLH (Manchester), Manchester Centre for Genomic Medicine, Manchester University NHS Foundation Trust, Manchester, England, United Kingdom.
Michael BraunColorectal and Peritoneal Oncology Centre, The Christie NHS Foundation Trust, Manchester, England, United Kingdom.ORCID 0000-0002-6666-4868
Caroline DiveCancer Research UK Manchester Institute, Cancer Biomarker Centre, University of Manchester, Manchester, England, United Kingdom.
D Gareth EvansDepartment of Genomic Medicine, Division of Evolution and Genomic Science, University of Manchester, England, United Kingdom.ORCID 0000-0002-8482-5784
Robert G BristowManchester Cancer Research Centre, CRUK Manchester Institute, University of Manchester, Manchester, England, United Kingdom.
Mark P SaundersColorectal and Peritoneal Oncology Centre, The Christie NHS Foundation Trust, Manchester, England, United Kingdom.
Sarah T O'DwyerColorectal and Peritoneal Oncology Centre, The Christie NHS Foundation Trust, Manchester, England, United Kingdom.
Omer AzizColorectal and Peritoneal Oncology Centre, The Christie NHS Foundation Trust, Manchester, England, United Kingdom. jorge.barriuso@manchester.ac.uk omer.aziz@manchester.ac.uk.ORCID 0000-0002-3765-2702
University of Manchester · GBManchester University NHS Foundation Trust · GBCancer Research UK Manchester Institute · GBThe Christie NHS Foundation Trust · GBCenter for Genomic Science · IT

Funding

Cancer Research UK 29365Cancer Research UK 29420Cancer Research UK 29569
6 · The paper itself

Abstract

purposeAt diagnosis, colorectal cancer presents with synchronous peritoneal metastasis in up to 10% of patients. The peritoneum is poorly characterized with respect to its superspecialized microenvironment. Our aim was to describe the differences between peritoneal metastases and their matched primary tumors excised simultaneously at the time of surgery. Also, we tested the hypothesis of these differences being present in primary colorectal tumors and having prognostic capacity. EXPERIMENTAL

designWe report a comprehensive analysis of 30 samples from peritoneal metastasis with their matched colorectal cancer primaries obtained during cytoreductive surgery. We tested and validated the prognostic value of our findings in a pooled series of 660 colorectal cancer primary samples with overall survival (OS) information and 743 samples with disease-free survival (DFS) information from publicly available databases.

resultsWe identified 20 genes dysregulated in peritoneal metastasis that promote an early increasing role of "stemness" in conjunction with tumor-favorable inflammatory changes. When adjusted for age, gender, and stage, the 20-gene peritoneal signature proved to have prognostic value for both OS [adjusted HR for the high-risk group (vs. low-risk) 2.32 (95% confidence interval, CI, 1.69-3.19;

conclusionsOur findings indicated that the activation of "stemness" pathways and adaptation to the peritoneal-specific environment are key to early stages of peritoneal carcinomatosis. The

Indexed as

AdultAgedColorectal NeoplasmsCytoreduction Surgical ProceduresDisease-Free SurvivalFemaleFollow-Up StudiesHumansHyperthermic Intraperitoneal ChemotherapyMaleMiddle AgedNeoplasm Recurrence, LocalNeoplastic Stem CellsPeritoneal CavityPeritoneal NeoplasmsRisk Assessment

Identifiers

PMID33257424
PMCPMC7611320
OpenAlexW3107778596

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.